Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$31.71 - $38.95 $697 - $856
22 New
22 $0
Q1 2023

May 12, 2023

BUY
$37.58 - $52.57 $4,284 - $5,992
114 New
114 $4,000
Q4 2021

Feb 14, 2022

SELL
$74.57 - $87.19 $14,317 - $16,740
-192 Reduced 30.09%
446 $38,000
Q3 2021

Nov 12, 2021

SELL
$73.77 - $83.61 $12,098 - $13,712
-164 Reduced 20.45%
638 $51,000
Q4 2020

Feb 12, 2021

SELL
$75.39 - $82.36 $81,421 - $88,948
-1,080 Reduced 57.39%
802 $64,000
Q3 2020

Nov 12, 2020

SELL
$78.33 - $90.73 $26,788 - $31,029
-342 Reduced 15.38%
1,882 $151,000
Q2 2020

Aug 11, 2020

SELL
$78.66 - $94.14 $83,222 - $99,600
-1,058 Reduced 32.24%
2,224 $191,000
Q1 2020

May 14, 2020

SELL
$71.57 - $93.3 $209,485 - $273,089
-2,927 Reduced 47.14%
3,282 $267,000
Q4 2019

Feb 14, 2020

SELL
$76.7 - $88.45 $1.29 Million - $1.48 Million
-16,781 Reduced 72.99%
6,209 $519,000
Q3 2019

Nov 12, 2019

BUY
$81.4 - $89.78 $16,361 - $18,045
201 Added 0.88%
22,990 $2.01 Million
Q2 2019

Aug 09, 2019

BUY
$73.44 - $82.41 $68,739 - $77,135
936 Added 4.28%
22,789 $1.87 Million
Q1 2019

May 13, 2019

SELL
$64.48 - $81.31 $17,860 - $22,522
-277 Reduced 1.25%
21,853 $1.78 Million
Q4 2018

Feb 11, 2019

SELL
$61.45 - $77.8 $253,727 - $321,236
-4,129 Reduced 15.72%
22,130 $1.46 Million
Q3 2018

Nov 09, 2018

BUY
$70.71 - $77.75 $309,992 - $340,856
4,384 Added 20.04%
26,259 $2.02 Million
Q2 2018

Aug 07, 2018

SELL
$63.43 - $75.41 $244,015 - $290,102
-3,847 Reduced 14.96%
21,875 $1.62 Million
Q1 2018

May 07, 2018

BUY
$62.56 - $72.26 $96,780 - $111,786
1,547 Added 6.4%
25,722 $1.67 Million
Q4 2017

Feb 12, 2018

BUY
$61.45 - $66.05 $192,768 - $207,198
3,137 Added 14.91%
24,175 $1.56 Million
Q3 2017

Nov 09, 2017

BUY
$59.5 - $64.61 $1.25 Million - $1.36 Million
21,038
21,038 $1.32 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $19.8B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Johnson Financial Group, Inc. Portfolio

Follow Johnson Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Johnson Financial Group, Inc. with notifications on news.